In this week’s episode of RealClear Radio Hour, we tackle the war on cancer. Disruptive innovators, Stephen Bonner and Paul Davies, confront bureaucracy and big science to put patients first and introduce cutting-edge research.
My first guest this week is Stephen Bonner, Entrepreneur in Residence at Harvard Business School and board member and former president and CEO of the Cancer Treatment Centers of America (CTCA) from 1999 to 2014. Bonner discusses the consumer experience and innovations in health care—from experimental treatments to Right-to-Try legislation. He shares how CTCA was founded to offer patient-centric, integrative care for complex, late-stage cancers, challenging the traditional treatment model designed by and for bureaucrats at the Food and Drug Administration, American Medical Association, and health insurance companies.
Wrapping up the show is Paul Davies, theoretical physicist, cosmologist, astrobiologist, best-selling author, and Principal Investigator at the Center for the Convergence of Physical Science and Cancer Biology at Arizona State University. Davies discusses big science and the $1 trillion “war on cancer.” He shares how he was invited by the National Institutes of Health to develop new approaches to tackling this complex constellation of diseases. His unconventional theoretical framework points to cancer as a retriggered ancestral cellular mechanism, suggesting a range of alternative treatments worth exploring.
You can hear the discussion by listening to the full show as-aired on iTunes, or you can check out the podcasts hosted on YouTube and SoundCloud. Make sure to check back next week for another episode of RealClear Radio Hour.